343 related articles for article (PubMed ID: 12060588)
1. Cyclooxygenase-2 products compensate for inhibition of nitric oxide regulation of renal perfusion.
Beierwaltes WH
Am J Physiol Renal Physiol; 2002 Jul; 283(1):F68-72. PubMed ID: 12060588
[TBL] [Abstract][Full Text] [Related]
2. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 participates in tubular flow-dependent afferent arteriolar tone: interaction with neuronal NOS.
Ichihara A; Imig JD; Inscho EW; Navar LG
Am J Physiol; 1998 Oct; 275(4):F605-12. PubMed ID: 9755132
[TBL] [Abstract][Full Text] [Related]
4. Adaptation of the hypothalamic blood flow to chronic nitric oxide deficiency is independent of vasodilator prostanoids.
Hortobágyi L; Kis B; Hrabák A; Horváth B; Huszty G; Schweer H; Benyó B; Sándor P; Busija DW; Benyó Z
Brain Res; 2007 Feb; 1131(1):129-37. PubMed ID: 17161389
[TBL] [Abstract][Full Text] [Related]
5. Role of cyclooxygenase-2-derived metabolites and nitric oxide in regulating renal function.
Llinás MT; Rodríguez F; Moreno C; Salazar FJ
Am J Physiol Regul Integr Comp Physiol; 2000 Nov; 279(5):R1641-6. PubMed ID: 11049846
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide synthase-inhibition hypertension is associated with altered endothelial cyclooxygenase function.
Bratz IN; Kanagy NL
Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2394-401. PubMed ID: 15319202
[TBL] [Abstract][Full Text] [Related]
7. Relative roles of nitric oxide, prostanoids and angiotensin II in the regulation of canine glomerular hemodynamics. A micropuncture study.
Kramer HJ; Horacek V; Bäcker A; Vaneckova I; Heller J
Kidney Blood Press Res; 2004; 27(1):10-7. PubMed ID: 14583658
[TBL] [Abstract][Full Text] [Related]
8. Influence of nitric oxide in the chronic phase of two-kidney, one clip renovascular hypertension.
Sigmon DH; Beierwaltes WH
Hypertension; 1998 Feb; 31(2):649-56. PubMed ID: 9461236
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the myogenic response in renal blood flow autoregulation by NO depends on endothelial nitric oxide synthase (eNOS), but not neuronal or inducible NOS.
Dautzenberg M; Keilhoff G; Just A
J Physiol; 2011 Oct; 589(Pt 19):4731-44. PubMed ID: 21825026
[TBL] [Abstract][Full Text] [Related]
10. Long-term fenofibrate treatment impairs endothelium-dependent dilation to acetylcholine by altering the cyclooxygenase pathway.
Blanco-Rivero J; Márquez-Rodas I; Xavier FE; Aras-López R; Arroyo-Villa I; Ferrer M; Balfagón G
Cardiovasc Res; 2007 Jul; 75(2):398-407. PubMed ID: 17412316
[TBL] [Abstract][Full Text] [Related]
11. Support of renal blood flow after ischaemic-reperfusion injury by endogenous formation of nitric oxide and of cyclo-oxygenase vasodilator metabolites.
Cristol JP; Thiemermann C; Mitchell JA; Walder C; Vane JR
Br J Pharmacol; 1993 May; 109(1):188-94. PubMed ID: 7684301
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase 2 and neuronal nitric oxide synthase expression in the renal cortex are not interdependent in states of salt deficiency.
Castrop H; Kammerl M; Mann B; Jensen BL; Krämer BK; Kurtz A
Pflugers Arch; 2000 Dec; 441(2-3):235-40. PubMed ID: 11211108
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide (NO) modulation of PAF-induced cardiopulmonary action: interaction between NO synthase and cyclo-oxygenase-2 pathways.
Fabi F; Calabrese R; Stati T; del Basso P
Br J Pharmacol; 2001 Oct; 134(4):777-88. PubMed ID: 11606318
[TBL] [Abstract][Full Text] [Related]
14. Role of neuronal nitric oxide in the inhibition of sympathetic vasoconstriction in resting and contracting skeletal muscle of healthy rats.
Jendzjowsky NG; DeLorey DS
J Appl Physiol (1985); 2013 Jul; 115(1):97-106. PubMed ID: 23640592
[TBL] [Abstract][Full Text] [Related]
15. Relationship between basal NO release and cyclooxygenase products in the normal rat kidney.
Baylis C; Slangen B; Hussain S; Weaver C
Am J Physiol; 1996 Nov; 271(5 Pt 2):R1327-34. PubMed ID: 8945971
[TBL] [Abstract][Full Text] [Related]
16. Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2.
Henrion D; Dechaux E; Dowell FJ; Maclour J; Samuel JL; Lévy BI; Michel JB
Br J Pharmacol; 1997 May; 121(1):83-90. PubMed ID: 9146891
[TBL] [Abstract][Full Text] [Related]
17. Differential salutary effects of nonselective and selective COX-2 inhibitors in postoperative ileus in rats.
Korolkiewicz RP; Ujda M; Dabkowski J; Ruczyński J; Rekowski P; Petrusewicz J
J Surg Res; 2003 Feb; 109(2):161-9. PubMed ID: 12643859
[TBL] [Abstract][Full Text] [Related]
18. Induction of small intestinal damage in rats following combined treatment with cyclooxygenase-2 and nitric-oxide synthase inhibitors.
Ohno R; Yokota A; Tanaka A; Takeuchi K
J Pharmacol Exp Ther; 2004 Aug; 310(2):821-7. PubMed ID: 15044560
[TBL] [Abstract][Full Text] [Related]
19. Chronic inhibition of nitric-oxide synthase potentiates endothelium-dependent contractions in the rat aorta by augmenting the expression of cyclooxygenase-2.
Qu C; Leung SW; Vanhoutte PM; Man RY
J Pharmacol Exp Ther; 2010 Aug; 334(2):373-80. PubMed ID: 20444882
[TBL] [Abstract][Full Text] [Related]
20. Effects of connexin-mimetic peptides on nitric oxide synthase- and cyclooxygenase-independent renal vasodilation.
De Vriese AS; Van de Voorde J; Lameire NH
Kidney Int; 2002 Jan; 61(1):177-85. PubMed ID: 11786099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
